Cargando…
Glomerular filtration rate estimation for carboplatin dosing in patients with gynaecological cancers
BACKGROUND: Carboplatin remains integral for treatment of gynaecological malignancies and dosing is based on glomerular filtration rate (GFR). Measurement via radiotracer decay [nuclear medicine GFR (nmGFR)] is ideal. However, this may be unavailable. Therefore GFR is often estimated using formulae...
Autores principales: | Samani, A., Bennett, R., Eremeishvili, K., Kalofonou, F., Whear, S., Montes, A., Kristeleit, R., Krell, J., McNeish, I., Ghosh, S., Tookman, L. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9058909/ https://www.ncbi.nlm.nih.gov/pubmed/35227967 http://dx.doi.org/10.1016/j.esmoop.2022.100401 |
Ejemplares similares
-
Response to the letter entitled “Glomerular filtration rate estimation for carboplatin dosing in patients with gynaecological cancers”
por: Samani, A., et al.
Publicado: (2022) -
Letter comments on: Glomerular filtration rate estimation for carboplatin dosing in patients with gynaecological cancers
por: Cartwright, D., et al.
Publicado: (2022) -
Carboplatin Dosing in Children Using Estimated Glomerular Filtration Rate: Equation Matters
por: van de Velde, Mirjam E., et al.
Publicado: (2021) -
Safe administration of chemotherapy in mast cell activation syndrome
por: Lythgoe, MP, et al.
Publicado: (2020) -
Practical guidance for the management of side effects during
rucaparib therapy in a multidisciplinary UK setting
por: Tookman, Laura, et al.
Publicado: (2020)